5-142314648-T-C

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001127496.3(SPRY4):​c.461A>G​(p.Lys154Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00227 in 1,614,212 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0024 ( 6 hom. )

Consequence

SPRY4
NM_001127496.3 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:3

Conservation

PhyloP100: 7.64

Publications

11 publications found
Variant links:
Genes affected
SPRY4 (HGNC:15533): (sprouty RTK signaling antagonist 4) This gene encodes a member of a family of cysteine- and proline-rich proteins. The encoded protein is an inhibitor of the receptor-transduced mitogen-activated protein kinase (MAPK) signaling pathway. Activity of this protein impairs the formation of active GTP-RAS. Nucleotide variation in this gene has been associated with hypogonadotropic hypogonadism 17 with or without anosmia. Alternative splicing results in a multiple transcript variants. [provided by RefSeq, Jun 2014]
SPRY4 Gene-Disease associations (from GenCC):
  • hypogonadotropic hypogonadism
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Kallmann syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypogonadotropic hypogonadism 17 with or without anosmia
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0137890875).
BP6
Variant 5-142314648-T-C is Benign according to our data. Variant chr5-142314648-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 50872.
BS2
High AC in GnomAd4 at 190 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPRY4NM_001127496.3 linkc.461A>G p.Lys154Arg missense_variant Exon 2 of 2 ENST00000434127.3 NP_001120968.1 Q9C004-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPRY4ENST00000434127.3 linkc.461A>G p.Lys154Arg missense_variant Exon 2 of 2 1 NM_001127496.3 ENSP00000399468.2 Q9C004-1
SPRY4ENST00000344120.4 linkc.530A>G p.Lys177Arg missense_variant Exon 3 of 3 1 ENSP00000344967.4 A0A0C4DFS6
SPRY4ENST00000643792.1 linkn.1143A>G non_coding_transcript_exon_variant Exon 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.00124
AC:
189
AN:
152220
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000458
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.000392
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00201
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00160
AC:
401
AN:
251202
AF XY:
0.00182
show subpopulations
Gnomad AFR exome
AF:
0.000309
Gnomad AMR exome
AF:
0.00104
Gnomad ASJ exome
AF:
0.000497
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000323
Gnomad NFE exome
AF:
0.00235
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.00237
AC:
3471
AN:
1461874
Hom.:
6
Cov.:
32
AF XY:
0.00241
AC XY:
1756
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.000329
AC:
11
AN:
33480
American (AMR)
AF:
0.000827
AC:
37
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000536
AC:
14
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00284
AC:
245
AN:
86258
European-Finnish (FIN)
AF:
0.000506
AC:
27
AN:
53406
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.00273
AC:
3036
AN:
1112008
Other (OTH)
AF:
0.00162
AC:
98
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
253
505
758
1010
1263
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
118
236
354
472
590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00125
AC:
190
AN:
152338
Hom.:
0
Cov.:
32
AF XY:
0.00121
AC XY:
90
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.000457
AC:
19
AN:
41580
American (AMR)
AF:
0.000392
AC:
6
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00269
AC:
13
AN:
4830
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00201
AC:
137
AN:
68022
Other (OTH)
AF:
0.00142
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
12
24
36
48
60
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00183
Hom.:
0
Bravo
AF:
0.00114
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00326
AC:
28
ExAC
AF:
0.00160
AC:
194
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00229
EpiControl
AF:
0.00219

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Oct 12, 2015
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SPRY4: BS2 -

Oct 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypogonadotropic hypogonadism 17 with or without anosmia Pathogenic:1
May 02, 2013
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

SPRY4-related disorder Benign:1
Feb 12, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.20
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.015
T;T
Eigen
Uncertain
0.51
Eigen_PC
Uncertain
0.50
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.79
T;T
M_CAP
Benign
0.026
D
MetaRNN
Benign
0.014
T;T
MetaSVM
Benign
-0.60
T
MutationAssessor
Uncertain
2.4
.;M
PhyloP100
7.6
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-0.76
N;N
REVEL
Benign
0.20
Sift
Benign
0.21
T;T
Sift4G
Benign
0.52
T;T
Polyphen
1.0
.;D
Vest4
0.51
MVP
0.88
MPC
1.0
ClinPred
0.042
T
GERP RS
4.4
Varity_R
0.21
gMVP
0.27
Mutation Taster
=73/27
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78310959; hg19: chr5-141694213; API